Clinical Trial

Anti-citrullinated SR-A Peptide (Anti-csp) Antibody as a Biomarker in Rheumatoid Arthritis (RA).

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
1. To measure serum level of anticitrullinated SR-A peptide antibody (anti-CSP) in RA patients compared to healthy controls . 2. To assess the diagnostic performance of anti-CSP for RA specifically seronegative RA patients. 3. To evaluate correlation of serum anti-CSP level with disease activity and functional disability scores in RA patients.
Trial Details
NCT Number NCT07147127
Lead Sponsor Walaa sharif Eid Ahmed
Conditions Rheumatoid Arthritis (RA)
Enrollment 81 participants
Start Date 2026-01
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-28